Applications published 25 October 2006

Natural tea having effects of hangover relief and liver function recovery and method for preparing the same
Nam, Jong-Hyun 1713346*

Pharmaceutical preparation for the oral cavity
Therapicon 1713439*

Engineered proteins, and methods of making and using
The California Institute of Technology; The Regents of the University of California-San Francisco 1713440*

Interleukin-13 antagonist powders, spray-dried particles, and methods
Nektar Therapeutics 1713441*

Semisolid matrix pharmaceutical formulations
Pfizer Italia 1713442*

Nanosuspensions of anti-retroviral agents for increased central nervous system delivery
Baxter International; Baxter Healthcare 1713443*

A microemulsion preparation of high concentration propopfol for anaesthetic uses
Bioavailability 1713444*

Non-lamellar compsns of dioleotl phospatidyethanolamine and polysorbate 80
Camarus 1713445*

Ternary non-lamellar lipid compsns
Camarus 1713446*

Particulate plant sterol compsns
Cargill 1713447*

Stable beadlets of lipophilic nutrients
OmniActive Health Technologies 1713448*

Nonabrasive sensory exfoliating system
E-L Management 1713449*

Rapidly dissolving film for delivery of an active agent
Corium International; AV Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences 1713450*

Solid dosage forms of galanthamine
Actavis 1713451*

Sustained release pharmaceutical compsn of indapamide
Krka 1713452*

Implantable drug delivery device including wire filaments
Conor Medsystems 1713453*

Enteric delivery of (-)-hydroxycitric acid
Glykon Technologies 1713454*

Method for producing sorbicillactone A
Johannes Gutenburg-Universitaet Mainz; Julius-Maximillians-Universitaet Wurzburg 1713455*

Rectal compsn
LTP Lipid Technologies Provider 1713456*

Novel drugs and diagnostic compsns for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
Max-Delbrueck-Centrum fuer Molekulare Medizin 1713457*

Method for enhancing the bioavailability of ospemifene
Hormos Medical 1713458*

Use of sphingosine-1-phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases
Novartis 1713459*

FK228 analogues and their use as HDAC-inhibitors
Wisconsin Alumni Research Foundation 1713460*

Compounds having antitumour activity
Defiante Farmaeutica 1713461*

A method of modulating pro-inflammatory and inflammatory activity mediated by C-reactive protein
Medvet Science Pty 1713462*

Reelin deficiency or dysfunction and methods related thereto
Martek Biosciences 1713463*

Glycione and/or proline for use in cartilage affecting conditions
Hill's Pet Nutrition 1713464*

Compounds and compsns as LXR modulators
IRM 1713465*

Antiparasitic compsn containing an organic amine salt of closantel
Wyeth 1713466*

Compsns and methods of use of A-type procyanidins
Mars 1713467*

Anthelmintic compsn
Wyeth 1713468*

Hypocholesterolemic compsns comprising a statin and an anti-flatulent agent
Ferrer Internacional 1713469*

Therapeutic combinations
Pfizer 1713470*

Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
MEDA Pharma 1713471*

Treatment of rhinitis with anticholinergics alone in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids
MEDA Pharma 1713472*

The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD
MEDA Pharma 1713473*

Indirubin derivatives having anti-cancer property against human cancer cell ME
Anygen 1713474*

1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
Solvay Pharmaceuticals 1713475*

Rabeprazole containing formulation
Lyka Labs 1713476*

Combination of voriconazole and an antifungal CYP2C19 inhibitor
Pfizer 1713477*

Compsns comprising HIV protease inhibitor and cytochrome p450 enzyme activity inhibitor
Pfizer 1713478*

NK1 receptor antagonists anaesthesia recovery
Pfizer Products 1713479*

The use of quaternary pyridinium salts as vasoprotective agents
Pharmena 1713480*

Novel uses for proton pump inhibitors
Istituto Superiore di Sanita' 1713481*

2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-2S-phenyl-piperidin-3S-yl)-amine for the treatment of social phobia
Glaxo 1713482*

Chemokine inhibiting piperazine derivatives and their use to treat multiple myeloma
Schering; University of Pittsburgh of the Commonwealth System of Higher Education 1713483*

Compounds and methods of use
Amgen 1713484*

Treatment of degenerative cartilage conditions in a mammal with glycosidase inhibitors
Optimer Pharmaceuticals; The Scripps Research Institute 1713485*

Combination therapy for dementia, depression and apathy
Sheldon, Leslie James 1713486*

Diazabicyclic aryl derivatives as cholinergic receptor modulators
Neurosearch 1713487*

Treatment of psychoses with quetiapine antipsychotic
AstraZeneca 1713488*

Solid and crystalline ibandronate sodium and processes for preparation thereof
Teva Pharmaceutical Industries 1713489*

Compsns for the treatment of atopic dermatitis, skin allergic conditions and acne
Indena 1713490*

Effervescent compsn including cranberry extract
Amerilab Technologies 1713492*

Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
Bayer Pharmaceuticals 1713493*

Treatment of conditions involving dopaminergic neuronal degeneration using NOGO receptor antagonists
Biogen Idec; Yale University 1713494*

Method of inducing or modulating immune response
Metcalfe, Susan Marie 1713495*

Use of factor VIIA for treating trauma
Novo Nordisk 1713496*

Use of factor VIIA for treating late complications of trauma
Novo Nordisk 1713497*

Compsn comprising polymeric material and uses thereof
Transfert Plus 1713498*

Methods and compsns for modulating triglyceride and VLDL secretion
The University of Manitoba 1713499*

Use of aerosolised antithrombin to treat acute lung injury
GTC Biotherapeutics 1713500*

Treatment of neurodegenerative diseases by the use of GPR49
Cellzome 1713501*

Highly-concentrated liquid formulations of anti-EGFR antibodies
Merck Patent 1713502*

Inhibition of factor B, the alternative complement pathway and methods related thereto
The Regents of the University of Colorado; National Jewish Medical and Research Centre; MUSC Foundation for Research Development 1713503*

Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
Pfizer Products 1713504*

Method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity, and use thereof
Pleuran 1713505*

Pharmaceutical compsns of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
Pfizer 1713506*

Adept or Gdept production of acetaldehyde
Savage, Philip 1713507*

Use of amino-oxy functional groups in the preparation of vaccine conjugates
Biosynexus 1713508*

Method for producing conjugates of polysaccharides and polynucleotides
Noxxon Pharma 1713509*

Growth factor-binding compounds attached to a calixarene
University of South Florida; Yale University 1713510*

Therapeutic agent for treatment of cancer comprising human apolipoprotein (A) kringles LK68 or LK8 genes as effective ingredient, and treatment for cancer using the same
Mogam Biotechnology Research Institute 1713511*